CDCP1 and lung cancer: To further demonstrate that the suppressed oncogenic properties of miR-218 directly through target CDCP1, western blot analysis and cell migration assays were performed in lung cancer F4 cells over-expressing pri-mir-218 and/or CDCP1 lacking 3′UTR (Fig. 4E,F).